EUVIMEDEUVIMED entdecken
Crossref

COVID ‐19 Infection Increases the Risk of Subsequent Diagnosis of Chronic Rhinosinusitis

Zachary Whong iD, Avni Malik, Alyssa N Calder, Michael F Armstrong, Theodore A Schuman

The Laryngoscope · 2026-07 · 136 (7) · 2925-2930

DOI: 10.1002/lary.70444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 16.02.2026. Verfasst von Zachary Whong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: COVID-19, Rhinosinusitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To analyze the impact of COVID‐19 infection on the diagnosis of chronic rhinosinusitis (CRS).

Methods

TriNetX, a large international database of anonymized health records, was queried for adults with either positive or negative SARS‐CoV‐2 polymerase chain reaction (PCR) tests between March 1, 2020 and December 31, 2024. Patients with cancer or immunodeficiency before the COVID‐19 diagnosis were excluded. Propensity score matching was used to create comparable exposure and control groups. Relative risk ratios and Cox proportional hazards regression analysis of CRS diagnosis were calculated 3 months after PCR testing. Sub‐analyses were completed to investigate the effects of prior COVID‐19 infection on subsequent CRS development stratified by prior vaccination status and by variant‐dominant time periods (pre‐Delta, Delta, and Omicron).

Results

Propensity score‐matched COVID‐19+ and COVID‐19− cohorts each consisted of 2,135,446 patients. Rate of diagnosis of CRS increased following a positive COVID‐19 PCR test (RR = 2.13, 95% CI [2.10–2.16]) and varied across variant‐dominant periods, with risk ratios of 1.44 (95% CI [1.41–1.47]) during pre‐Delta, 1.20 (95% CI [1.15–1.25]) during Delta, and 2.10 (95% CI [2.07–2.13]) during Omicron. Prior COVID‐19 vaccination did not modify the risk of CRS among patients with a positive COVID‐19 PCR (RR = 0.98, 95% CI [0.92–1.05]).

Conclusions

COVID‐19 infection was found to increase the risk of subsequent diagnosis of CRS. Further studies are needed to better understand the relationship between COVID‐19 and the development of sinonasal inflammatory pathology. Level of Evidence 3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19RhinosinusitisAdultAgedFemaleHumansMaleMiddle AgedChronic DiseaseRisk FactorsSARS-CoV-2

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2TriNetXchronic rhinosinusitislong COVIDpost‐viral sequelaesinonasal disease

Autor:innen und Institutionen

  • Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.

ORCID-Profile: Zachary Whong

Zitieren

APA

Whong, Z., Malik, A., Calder, A. N., Armstrong, M. F., & Schuman, T. A. (2026). COVID ‐19 Infection Increases the Risk of Subsequent Diagnosis of Chronic Rhinosinusitis. The Laryngoscope, 136(7), 2925-2930. https://doi.org/10.1002/lary.70444

Vancouver

Whong Z, Malik A, Calder AN, Armstrong MF, Schuman TA. COVID ‐19 Infection Increases the Risk of Subsequent Diagnosis of Chronic Rhinosinusitis. The Laryngoscope. 2026;136(7):2925-2930. doi:10.1002/lary.70444

BibTeX
@article{Whong2026,
  author = {Whong, Zachary and Malik, Avni and Calder, Alyssa N and Armstrong, Michael F and Schuman, Theodore A},
  title = {COVID ‐19 Infection Increases the Risk of Subsequent Diagnosis of Chronic Rhinosinusitis},
  journal = {The Laryngoscope},
  year = {2026},
  volume = {136},
  number = {7},
  pages = {2925--2930},
  doi = {10.1002/lary.70444}
}
Kostenlos starten →